We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

111 hedge funds and large institutions have $114M invested in Asensus Surgical, Inc. in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 30

6% more call options, than puts

Call options by funds: $3.81M | Put options by funds: $3.58M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 119111 (-8)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

38% less capital invested

Capital invested by funds: $184M → $114M (-$69.7M)

Holders
111
Holders Change
-8
Holders Change %
-6.72%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
34
Reduced
30
Closed
17
Calls
$3.81M
Puts
$3.58M
Net Calls
+$227K
Net Calls Change
-$1.73M
Name Holding Trade Value Shares
Change
Change in
Stake
Wolverine Trading
51
Wolverine Trading
Illinois
$82K +$12.4K +5,518 +13%
MLICM
52
Metropolitan Life Insurance Company (MetLife)
New York
$82K -$53.9K -24,002 -35%
PFS
53
Prospera Financial Services
Texas
$75K -$95.4K -42,500 -51%
Cambridge Investment Research Advisors
54
Cambridge Investment Research Advisors
Iowa
$73K -$13.5K -6,000 -13%
MCP
55
Mirador Capital Partners
California
$71K
AB
56
Amalgamated Bank
New York
$65K -$3.21K -1,429 -4%
Victory Capital Management
57
Victory Capital Management
Texas
$61K -$5.02K -2,237 -6%
RJA
58
Raymond James & Associates
Florida
$58K -$35.2K -15,697 -33%
CM
59
Caption Management
Oklahoma
$56K
ProShare Advisors
60
ProShare Advisors
Maryland
$55K -$69K -30,719 -51%
Commonwealth Equity Services
61
Commonwealth Equity Services
Massachusetts
$53K +$6.1K +2,716 +10%
Daiwa Securities Group
62
Daiwa Securities Group
Japan
$44K +$53K +23,596 New
IUHSA
63
Itau Unibanco Holding S.A.
Brazil
$39K +$15.1K +6,743 +48%
TRCT
64
Tower Research Capital (TRC)
New York
$39K +$31.2K +13,873 +189%
Legal & General Group
65
Legal & General Group
United Kingdom
$38K
RJFSA
66
Raymond James Financial Services Advisors
Florida
$37K -$14.4K -6,395 -24%
AIP
67
Ameritas Investment Partners
Nebraska
$34K
DTL
68
Dynamic Technology Lab
Singapore
$33K +$39.5K +17,579 New
CSM
69
CAMG Solamere Management
North Carolina
$31K +$37.5K +16,693 New
Prudential Financial
70
Prudential Financial
New Jersey
$30K +$3.03K +1,350 +9%
Mackenzie Financial
71
Mackenzie Financial
Ontario, Canada
$25K +$30.8K +13,712 New
BRWA
72
B. Riley Wealth Advisors
Florida
$24K -$11.9K -5,310 -29%
OCM
73
One Capital Management
California
$24K
PPA
74
Parametric Portfolio Associates
Washington
$23K +$28.2K +12,565 New
X
75
Xponance
Pennsylvania
$20K -$4.07K -1,814 -14%

ASXC Hedge Fund Activity: Q3 2021 in Review

111 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q3 2021, worth a combined $114M — down 38% from $184M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ASXC and 11 opened new positions — a net loss of 6 holders — while 30 trimmed existing stakes and 34 added.

The largest buyer was State Street, adding an estimated $11.9M. The largest seller was Sabby Management, exiting entirely with an estimated $2.95M sold.

  • 111 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q3 2021, down from 119 in Q2 2021.
  • Funds reported $114M of Asensus Surgical, Inc. stock for Q3 2021, down 38% quarter-over-quarter.
  • 11 funds opened new Asensus Surgical, Inc. positions in Q3 2021 and 17 closed out, a net change of -6 holders.
  • The largest Asensus Surgical, Inc. buyer in Q3 2021 was State Street, an estimated $11.9M added.
  • The largest Asensus Surgical, Inc. seller in Q3 2021 was Sabby Management, an estimated $2.95M sold.

Based on aggregated 13F filings for Q3 2021.